DEC 12, 2018 04:26 PM PST

Switch HIV Infection

The human immunodeficiency virus continues to be a threat to a large population of people today. No effective cure exists for HIV. Even with preventative treatment and medical care after infection, the transfer and persistence of the virus can endure. Latent HIV infection remains elusive to the immune system allowing for it to thrive undetected in the body.

In a recently shared study in the journal Proceedings of the National Academy of Sciences, performed by researchers at the University of Illinois at Chicago, data suggest that a genetic switch that causes latent HIV infected cells to begin to replicate can be manipulated to eradicate the virus from the body completely. Over time, HIV can destroy so many of these cells that the body can’t fight off infections and disease. These specialized cells help the immune system fight off infections. Untreated, HIV reduces the number of CD4 cells (T cells) in the body.

The researchers share that, “the reservoir of HIV latently infected cells is the major obstacle for complete eradication of HIV infection. Latency and its transactivation in HIV-infected cells are controlled by the intracellular HIV Tat gene circuit.”

"We need to understand better the mechanisms that regulate HIV latency, so we can identify new opportunities for intervention and develop better drugs that can either lock viral particles in a latent state, or kill latent cells, or both," shared Liang, Professor of Bioengineering.

The scientists display that a genetic switch can be utilized as a cure for HIV infection. When HIV infects the genome of a cell, the Tat gene circuit controls the transcription of the viral DNA. As the Tat gene activates HIV, the cell becomes overburden with the virus and explodes, effectively permitting the infection of neighboring cells. The Tat gene is switched off during latent HIV infection.

"By targeting the Tat gene circuit with drugs or small molecules to activate it, we would be able to cause latently-infected cells to start producing more virus, and then they can be destroyed by the immune system," said Jie Liang, the Richard and Loan Hill Professor of Bioengineering in the University of Illinois at Chicago College of Engineering and a lead author of the paper. To date the drugs that aim for the tat gene to make these purposed changes.

The team finds that the Tat gene’s activation and inactivation is a spontaneous event and that its reactivation is rare. By making use of algorithms and models, their team was able to accurately map the probability of different reactions that cause Tat activation. The results of their studies provide new ways of targeting latent cells that may lead to the eradication of the HIV.

"Our results suggest that by controlling HIV latency through manipulation of the Tat gene circuit, effective therapeutic strategies can be identified that would one day provide a cure for HIV," Liang said.

Sources: PNAS, Science Daily, CDCYouTube

About the Author
You May Also Like
NOV 25, 2018
Health & Medicine
NOV 25, 2018
Why Does E. Coli Make us Sick?
  Escherichia coli, or E. coli refer to a diverse group of of bacteria commonly found in the lower intestine of warm blooded animals. While E. coli ga...
DEC 14, 2018
Videos
DEC 14, 2018
Anti-Opioid Vaccine is in Testing
Scientists at Virginia Commonwealth University are testing a vaccine created by Scripps Research Institute....
DEC 18, 2018
Health & Medicine
DEC 18, 2018
Mapping the Human Proteome
Advancing our understanding of human disease often requires a sound understanding of normal human physiology. A critical tool to provide guidance on human...
JAN 23, 2019
Immunology
JAN 23, 2019
Can Old Cells Have Positive Impacts on MS Patients?
A new study shows that there is a very limited regeneration of cells in the brain of patients diagnosed with multiple sclerosis (MS)....
MAR 06, 2019
Health & Medicine
MAR 06, 2019
A Second Patient Cured of HIV: Are We Close to a Cure for Everyone Infected?
There is a consensus that the first HIV infection occurred in the 1920s in Kinshasa, the Democratic Republic of Congo when it was passed to human...
APR 10, 2019
Immunology
APR 10, 2019
The Morel of the Story
It’s morel mushroom season in the United States and it promises to be a good one! Plenty of rain and warmth favor the growth of this delicatessen, bu...
Loading Comments...